Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Evotec SE

EVO ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Small Cap Analyst: HOLD

Last Close

$1.96

▼ -2.97%

Market Cap $706.69M · Vol 16.96K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$706.69M

Small Cap

Div Yield

0.00%

N/A

EPS Growth

-145.94%

YoY

RSI (14)

53.03

Momentum

Beta

2.02

vs Market

52W High

$4.27

54.10% below

52W Low

$1.90

3.16% above

Volume

16.96K

Avg 23.06K

P/B

1.14

Price-to-book

ROE

-6.36%

Return on equity

Free Float

100.00%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Evotec SE (EVO) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does EVO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.00%

-8.41%

-27.94%

-44.16%

YTD

-36.36%

-48.69%

-83.04%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$925.94M
Net Income	$-121,580,165.00
Revenue Growth (YoY)	-12.82%
Gross Margin	14.49%
Operating Margin	-12.58%
Net Profit Margin	-13.13%
ROE	-6.36%
ROA · ROIC	-4.79% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.23
P/B	1.14
P/FCF	N/A
EPS Growth	-145.94%
Outstanding Shares	177.91M

Technical Indicators

50-Day SMA	$2.38
200-Day SMA	$2.95
RSI (14)	53.03
Beta	2.02
52-Week High	$4.27
52-Week Low	$1.90

Volume Today	16.96K
Avg Daily Volume (30D)	23.06K
Relative Volume	0.74x
Volatility (10D)	55.09
Volatility (30D)	64.97
Free Float	100.00%

Analyst Consensus

HOLD

Current Price $1.96

Mean Target $2.80

52W Low$1.90 52W High$4.27

Current

Target

$1.90 $4.27

Current Analyst target

+42.86% upside potential · 3 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001T2N0N0

ISINUS30050E1055

CountryGermany

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateNov 6, 2026

TypeStocks

Instrument TypeADR American Depositary Receipt

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.